Table of Contents
Epidemiology Research International
Volume 2012 (2012), Article ID 241340, 10 pages
http://dx.doi.org/10.1155/2012/241340
Research Article

Using Simulation Modeling to Inform Strategies to Reduce Breast Cancer Mortality in Black Women in the District of Columbia

1Department of Oncology, Georgetown University Medical Center and Cancer Control Program, Lombardi Comprehensive Cancer Center, 3300 Whitehaven Street NW, Suite 4100, Washington, DC 20007, USA
2Departments of Family and Social Medicine and Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Mazer Building 406, Bronx, NY 10461, USA
3Department of Health Systems Administration, Georgetown University, 3700 Reservoir Road, NW Room 236, Washington, DC 20057-1107, USA

Received 30 October 2011; Accepted 26 April 2012

Academic Editor: Carolyn Rutter

Copyright © 2012 Aimee M. Near et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Healthy People 2020 (HP2020),” http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=5.
  2. SEER*Stat Database: Mortality—All COD. Aggregated With State, Total U.S. (1969–2006), Katrina/Rita Population Adjustment, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, 2009.
  3. SEER*Stat Database: Incidence—SEER 9 Regs Research Data. Nov 2008 Sub (1973–2006), Katrina/Rita Population Adjustment, —Linked To County Attributes—Total US, 1969–2006 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, 2009.
  4. Centers for Disease Control and Prevention (CDC), Behavioral Risk Factor Surveillance System Survey Data, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, Ga, USA, 1996–2008.
  5. DC Cancer Registry Dataset,, District of Columbia Department of Health, Washington, DC, USA, 1996–2007.
  6. N. T. van Ravesteyn, C. B. Schechter, A. M. Near et al., “Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States,” Cancer Epidemiology Biomarkers and Prevention, vol. 20, no. 1, pp. 112–122, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Mandelblatt, C. B. Schechter, W. Lawrence, B. Yi, and J. Cullen, “The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods,” Journal of the National Cancer Institute, no. 36, pp. 47–55, 2006. View at Google Scholar · View at Scopus
  8. http://cisnet.cancer.gov.
  9. American Community Survey Public Use Microdata Sample (PUMS) 2006–2008 3-Year Downloaded at, http://factfinder.census.gov/home/en/acs_pums_2008_3yr.html.
  10. T. R. Holford, K. A. Cronin, A. B. Mariotto, and E. J. Feuer, “Changing patterns in breast cancer incidence trends,” Journal of the National Cancer Institute, no. 36, pp. 19–25, 2006. View at Google Scholar · View at Scopus
  11. “Other cause adjustment references: Centers for Disease Control and Prevention, National Center for Health Statistics,” Multiple Cause of Death File 1999–2004. CDC WONDER On-line Database, compiled from Multiple Cause of Death File 1999–2004 Series 20 No. 2J http://wonder.cdc.gov/mcd-v2004.html, 2007.
  12. “Centers for Disease Control and Prevention, National Center for Health Statistics. Multiple Cause of Death File 2005-2006,” CDC WONDER On-line Database, compiled from Multiple Cause of Death File 2005-2006 Series 20 No. 2L http://wonder.cdc.gov/mcd-icd10.html, 2009.
  13. R. Ballard-Barbash, S. H. Taplin, B. C. Yankaskas et al., “Breast cancer surveillance consortium: a national mammography screening and outcomes database,” American Journal of Roentgenology, vol. 169, no. 4, pp. 1001–1008, 1997. View at Google Scholar · View at Scopus
  14. K. A. Cronin, A. B. Mariotto, L. D. Clarke, and E. J. Feuer, “Additional common inputs for analyzing impact of adjuvant therapy and mammography on U.S. mortality,” Journal of the National Cancer Institute, no. 36, pp. 26–29, 2006. View at Google Scholar · View at Scopus
  15. K. A. Cronin, B. Yu, M. Krapcho et al., “Modeling the dissemination of mammography in the United States,” Cancer Causes and Control, vol. 16, no. 6, pp. 701–712, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. K. S. Gill and B. C. Yankaskas, “Screening mammography performance and cancer detection among black women and white women in community practice,” Cancer, vol. 100, no. 1, pp. 139–148, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. D. S. May, N. C. Lee, L. C. Richardson, A. G. Giustozzi, and J. K. Bobo, “Mammography and breast cancer detection by race and Hispanic ethnicity: results from a national program (United States),” Cancer Causes and Control, vol. 11, no. 8, pp. 697–705, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. J. S. Mandelblatt, K. A. Cronin, S. Bailey et al., “Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms,” Annals of Internal Medicine, vol. 151, no. 10, pp. 738–747, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Mariotto, E. J. Feuer, L. C. Harlan, L. M. Wun, K. A. Johnson, and J. Abrams, “Trends in use of adjuvant multi-agent chemotherapy and tomoxifen for breast cancer in the United States: 1975–1999,” Journal of the National Cancer Institute, vol. 94, no. 21, pp. 1626–1634, 2002. View at Google Scholar · View at Scopus
  20. A. B. Mariotto, E. J. Feuer, L. C. Harlan, and J. Abrams, “Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975–1999,” Journal of the National Cancer Institute, no. 36, pp. 7–15, 2006. View at Google Scholar · View at Scopus
  21. Early Breast Cancer Trialists' Collaborative Group, “Polychemotherapy for early breast cancer: an overview of the randomised trials,” The Lancet, vol. 352, no. 9132, pp. 930–942, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. Early Breast Cancer Trialists' Collaborative Group, “Tamoxifen for early breast cancer: an overview of the randomised trials,” The Lancet, vol. 351, no. 9114, pp. 1451–1467, 1998. View at Google Scholar
  23. “Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials,” The Lancet, vol. 365, no. 9472, pp. 1687–1717, 2005.
  24. J. J. Dignam, “Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women,” Journal of the National Cancer Institute, no. 30, pp. 36–43, 2001. View at Google Scholar · View at Scopus
  25. DC Cancer Coalition, Facing the Challenge: DC Cancer Control Plan 2005–2010, Department of Health, Washington, DC, USA, 2006.
  26. P. Chang, A Simulation Study of Breast Cancer Epidemiology and Detection since 1982: the Case for Limited Malignant Potential Lesions—Dissertation, University of Wisconsin–Madison, Madison, Wis, USA, 1993.
  27. D. G. Fryback, N. K. Stout, M. A. Rosenberg, A. Trentham-Dietz, V. Kuruchittham, and P. L. Remington, “The wisconsin breast cancer epidemiology simulation model,” Journal of the National Cancer Institute, no. 36, pp. 37–47, 2006. View at Google Scholar · View at Scopus
  28. I. M. de Kok, M. Van Ballegooijen, and J. D. Habbema, “Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands,” Journal of the National Cancer Institute, vol. 101, no. 15, pp. 1083–1092, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Carter, P. Glasziou, G. Van Oortmarssen et al., “Cost-effectiveness of mammographic screening in Australia,” Australian Journal of Public Health, vol. 17, no. 1, pp. 42–50, 1993. View at Google Scholar · View at Scopus
  30. E. Paci, R. Boer, M. Zappa et al., “A model-based prediction of the impact on reduction in mortality by a breast cancer screening programme in the City of Florence, Italy,” European Journal of Cancer A, vol. 31, no. 3, pp. 348–353, 1995. View at Publisher · View at Google Scholar · View at Scopus
  31. E. van den Akker-van Marle, H. de Koning, R. Boer, and P. Van der Maas, “Reduction in breast cancer mortality due to the introduction of mass screening in the Netherlands: comparison with the United Kingdom,” Journal of Medical Screening, vol. 6, no. 1, pp. 30–34, 1999. View at Google Scholar · View at Scopus
  32. “Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement,” Annals of Internal Medicine, vol. 151, no. 10, pp. 716–726, 2009.
  33. J. S. Mandelblatt, W. Liang, V. B. Sheppard, J. Wang, and C. Isaacs, “Breast Cancer in minority women,” in Diseases of the Breast, J. Harris, M. Lippman, M. Morrow, and C. K. Osborne, Eds., Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 4th edition, 2009. View at Google Scholar